A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a \"dummy\" medicine (also called \"placebo\") that has no effect on the body. Participants will get either CagriSema or \"dummy\" medicine. Which treatment participants get is decided by chance. For each participant, the study will last for about one year.
Epistemonikos ID: 8385e54242ec9b6c9afbee75e3849fc49275fcf8
First added on: May 15, 2024